Synovial procollagenase activation by human mast cell tryptase dependence upon matrix metalloproteinase 3 activation.
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Mast cells have been implicated in the pathogenesis of the matrix degradation observed in the cartilaginous and osseous structures of the rheumatoid joint. We previously reported that human mast cell tryptase, a 134-kD granule-associated neutral protease, is present in rheumatoid synovium and can activate collagenase in crude culture medium in vitro. the present study attempts to depict the precise mechanism of this activation. To express full activation of latent collagenase, matrix metalloproteinase 3 (MMP-3) or stromelysin, can be activated by tryptase in a time and dose-dependent manner. Tryptase was not capable of generating active collagenase in the crude media from cultured rheumatoid synoviocytes depleted of proMMP-3 by immunoadsorption. In addition, the function of the tissue inhibitor of metalloproteinases (TIMP) was not altered by tryptase, and SDS-PAGE analysis revealed no degradation of TIMP by tryptase. The tryptase dependent activation of synoviocyte procollagenase thereby appears to be entirely dependent upon its ability to activate proMMP-3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4350 · Cited by 53,385
Raza, H., John, A., & Nemmar, A. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350087 · Cited by 47,221
Blake, M. S., Johnston, K. H., Russell-Jones, G. J., & Gotschlich, E. C. (1984) · Analytical Biochemistry · doi:10.1016/0003-2697(84)90320-8 · Cited by 2,136
Werb, Z., Mainardi, C. L., Vater, C. A., & Harris, E. D. (1977) · New England Journal of Medicine · doi:10.1056/nejm197705052961801 · Cited by 685
Dayer, J. M., de Rochemonteix, B., Burrus, B., Demczuk, S., & Dinarello, C. A. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112350 · Cited by 624
Okada, Y., Nagase, H., & Harris, E. D. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)67011-5 · Cited by 513
Self-citationChin, J. R., Murphy, G., & Werb, Z. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39034-8 · Cited by 495
Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes
Murphy, G., Cockett, M. I., Stephens, P. E., Smith, B. J., & Docherty, A. J. P. (1987) · Biochemical Journal · doi:10.1042/bj2480265 · Cited by 464
Tryptase from human pulmonary mast cells. Purification and characterization
Schwartz, L. B., Lewis, R. A., & Austen, K. F. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68496-6 · Cited by 419
Self-citation
Cited by
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
Ogata, Y., Enghild, J. J., & Nagase, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)50563-4 · Cited by 627
Self-citationKovanen, P. T., Kaartinen, M., & Paavonen, T. (1995) · Circulation · doi:10.1161/01.cir.92.5.1084 · Cited by 613
Interactions of Mast Cell Tryptase with Thrombin Receptors and PAR-2
Molino, M., Barnathan, E. S., Numerof, R., Clark, J., Dreyer, M., Cumashi, A., Hoxie, J. A., Schechter, N., Woolkalis, M., & Brass, L. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.7.4043 · Cited by 591
Kaartinen, M., Penttilä, A., & Kovanen, P. T. (1994) · Circulation · doi:10.1161/01.cir.90.4.1669 · Cited by 444
Thomas, C. V., Coker, M. L., Zellner, J. L., Handy, J. R., Crumbley, A. J., & Spinale, F. G. (1998) · Circulation · doi:10.1161/01.cir.97.17.1708 · Cited by 443
Mast cell tryptases and chymases in inflammation and host defense.
Caughey, G. H. (2007) · Immunological Reviews · doi:10.1111/j.1600-065x.2007.00509.x · Cited by 442
“The ability of mast cell chymases to activate MMP-9 and of b-tryptases to activate MMP cascades by cleaving pro-MMP-3 prompted speculation that these peptidases destabilize and help rupture atherosclerotic plaques (123, 131), which is thought to be a precipitating event in myocardial infarction.”
BackgroundHuman mast cells stimulate vascular tube formation. Tryptase is a novel, potent angiogenic factor.
Blair, R. J., Meng, H., Marchese, M. J., Ren, S., Schwartz, L. B., Tonnesen, M. G., & Gruber, B. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119458 · Cited by 439
Self-citationThe cell biology of leukocyte-mediated proteolysis
Owen, C. A., & Campbell, E. J. (1999) · Journal of Leukocyte Biology · doi:10.1002/jlb.65.2.137 · Cited by 439
Taipale, J., Lohi, J., Saarinen, J., Kovanen, P. T., & Keski-Oja, J. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4689 · Cited by 398
Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts
Cairns, J. A., & Walls, A. F. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119290 · Cited by 318
“This enzyme can degrade intact type VI collagen microfibrils (59), inactivate fibrinogen (23), and can activate latent collagenase by a process dependent on the activation of prostromelysin (24).”
BackgroundPejler, G., Åbrink, M., Ringvall, M., & Wernersson, S. (2007) · Advances in Immunology · doi:10.1016/s0065-2776(07)95006-3 · Cited by 320
Saarinen, J., Kalkkinen, N., Welgus, H. G., & Kovanen, P. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32427-4 · Cited by 315
Inokubo, Y., Hanada, H., Ishizaka, H., Fukushi, T., Kamada, T., & Okumura, K. (2001) · American Heart Journal · doi:10.1067/mhj.2001.112238 · Cited by 283
Activation of Matrix-Degrading Metalloproteinases by Mast Cell Proteases in Atherosclerotic Plaques
Johnson, J. L., Jackson, C. L., Angelini, G. D., & George, S. J. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.11.1707 · Cited by 265
Metalloproteinase inhibitors and the prevention of connective tissue breakdown
Cawston, T. E. (1996) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(96)00015-0 · Cited by 257
Pericellulars substrates of human mast cell tryptase: 72,000 Dalton gelatinase and fibronectin
Lohi, J., Kesksi‐Oja, J., & Harvima, I. (1992) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240500402 · Cited by 182
LEES, M., TAYLOR, D. J., & WOOLLEY, D. E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18980.x · Cited by 178
The differentiation and function of myofibroblasts is regulated by mast cell mediators
Gailit, J., Marchese, M. J., Kew, R. R., & Gruber, B. L. (2001) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2001.15211.x · Cited by 174
“Other myo®broblast functions, such as matrix deposition (Gruber et al, 1997) and matrix remodeling (Gruber et al, 1989), may be subject to regulation by tryptase as well.”
Self-citationJensen, F., Woudwyk, M., Teles, A., Woidacki, K., Taran, F., Costa, S., Malfertheiner, S. F., & Zenclussen, A. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014409 · Cited by 145
“Furthermore, MC tryptase has remarkably restricted substrate specificity for proteins, their substrates include proMMP-3 [49], urokinase type plasminogen activator [50], collagen VI [51], and a1 macroglobulin [52], while chymase is able to activate proMMP-1 [53].”
BackgroundCharacterization of genes encoding known and novel human mast cell tryptases on chromosome 16p13.3
Pallaoro, M., Fejzo, M. S., Shayesteh, L., Blount, J. L., & Caughey, G. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.6.3355 · Cited by 146
Douaiher, J., Succar, J., Lancerotto, L., Gurish, M. F., Orgill, D. P., Hamilton, M. J., Krilis, S. A., & Stevens, R. L. (2014) · Advances in Immunology · doi:10.1016/b978-0-12-800267-4.00006-7 · Cited by 131
Tryptase, a mediator of human mast cells
Schwartz, L. B. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80222-2 · Cited by 129
Self-citationDog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase.
Fang, K. C., Raymond, W. W., Lazarus, S. C., & Caughey, G. H. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118583 · Cited by 125
“Tryptase can activate collagenase indirectly via activation of urokinase, which then activates collagenase-activating plasmin (9), or by first activating stromelysin (7).”
BackgroundMast-cell responses in the development of asthma
Bingham, C. O., & Austen, K. F. (2000) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(00)90056-3 · Cited by 80
Chimenti, M. S., Sunzini, F., Fiorucci, L., Botti, E., Fonti, G. L., Conigliaro, P., Triggianese, P., Costa, L., Caso, F., Giunta, A., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02363 · Cited by 77
“In particular, synovial mast cells in vitro release tryptase and activate latent collagenase (64), participating to the development of the typical PsA synovial hypertrophy (65).”
BackgroundZhang, J., Nie, G., Jian, W., Woolley, D. E., & Salamonsen, L. A. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.3.693 · Cited by 69
(1990) · PubMed · Cited by 68
Inherited and acquired determinants of serum tryptase levels in humans
Lyons, J. J. (2021) · Annals of Allergy, Asthma & Immunology · doi:10.1016/j.anai.2021.06.019 · Cited by 52
Metadata
- Authors
- Gruber, B. L., Marchese, M. J., Suzuki, K., Schwartz, L. B., Okada, Y., Nagase, H., & Ramamurthy, N. S.
- Venue
- Journal of Clinical Investigation
- Published
- 1989-11-01
- Volume
- 84
- Issue
- 5
- Pages
- 1657-1662
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2162149799
- Cited by
- 348
- References
- 40
- FWCI
- 4.27
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.